[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-367629-105":59,"doc-detail-367629-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","association-of-prkcq-variants-with-breast-cancer-susceptibility-and-clinicopathological-features","Association of PRKCQ variants with breast cancer susceptibility and clinicopathological features","","Breast cancer remains a major cause of mortality worldwide, and genetic predisposition is a key risk determinant. This study evaluates the relationship between five pathogenic missense variants in the PRKCQ gene and the risk of breast cancer, tumor characteristics, and molecular types. Blood samples from 361 breast cancer patients and 364 cancer-free women were analyzed using phenol–chloroform DNA extraction and Tetra ARMS PCR genotyping. Associations were tested with Chi-square and Fisher’s exact tests, considering clinical parameters such as TNM staging, molecular subtypes, and metastasis. Several genotypes showed significant associations with disease risk and specific phenotypes, supporting PRKCQ variants as potential diagnostic, prognostic, and therapeutic biomarkers for targeted strategies.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/association-of-prkcq-variants-with-breast-cancer-susceptibility-and-clinicopathological-features/367629/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/association-of-prkcq-variants-with-breast-cancer-susceptibility-and-clinicopathological-features/367629.png","ImageObject",300,407,{"name":92,"@type":93},"Chumphorn","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What does the study investigate about PRKCQ variants?","Question",{"text":112,"@type":113},"It examines how five pathogenic missense variants in the PRKCQ gene relate to breast cancer susceptibility, tumor characteristics, and molecular types.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were the genetic variants genotyped and analyzed?",{"text":117,"@type":113},"Blood samples from patients and controls were processed for DNA extraction via phenol–chloroform, and genotyping was performed using Tetra ARMS PCR. Associations were evaluated using Chi-square and Fisher’s exact tests with GraphPad Prism.",{"name":119,"@type":110,"acceptedAnswer":120},"Which variant-genotype associations were highlighted in the results?",{"text":121,"@type":113},"The study reports significant links between specific genotypes and breast cancer risk and phenotype, including rs1248923790 TT with increased risk, and rs1403981107 AA with HER2+ disease and metastatic status.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},367629,1790480399,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},2336475401981,"https://ap-avatar.wpscdn.com/avatar/22000c94efd8d5204d?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786935347598174694","Hafeez et al. BMC Cancer (2025) 25:1069 BMC Cancer  \n[https://doi.org/10.1186/s12885-025-14471-8](https://doi.org/10.1186/s12885-025-14471-8)  \nRESEARCH Open Access  \nAssociation of PRKCQ variants with breast   cancer susceptibility and clinicopathological features  \nAmna Hafeez 1, Maria Shabbir 1*, Yasmin Badshah 1, Andleeb Farooq2, Janeen H. Trembley3,4,5, Tayyaba Afsar6, Dara Aldisi6 and Suhail Razak6*  \nAbstract  \nBackground Breast cancer (BC) continues to be the most common malignant neoplasm and leading cause of mortality in women globally and genetic predisposition is one of the important risk determinants of this disease. PRKCQ which encodes PKCθ contributes to several human cancers due to its crucial role in several cellular processes such as cell cycle progression, cell survival and immune response. The purpose of this study was to evaluate the relation between five pathogenic missense variants in the PRKCQ gene (rs1838691533, rs1248923790, rs1837738907, rs1837738573, and rs1403981107) and risks of breast cancer, tumor characteristics, and molecular types.  \nMethods Blood samples were collected from 361 breast cancer patients and 364 cancer-free women in hospitals in Islamabad and Rawalpindi, Pakistan. DNA extraction was performed using the phenol–chloroform method, and genotyping was conducted via Tetra ARMS PCR. Statistical analyses, including Chi-square and Fisher’s exact tests, were applied using GraphPad Prism to assess associations between PRKCQ genotypes and clinical parameters such asTNM staging, molecular subtypes, and metastasis.  \nResults Our results revealed significant associations between several genotypes and breast cancer risk. Among the analyzed variants, rs1248923790 TT was significantly associated with increased breast cancer risk (OR = 2 . 106,  \nRR = 1 .446, p \u003C 0. 0001), particularly in Luminal A BC (OR = 2 . 530, p \u003C 0. 0001), while the CT genotype was more frequent in late-stage and metastatic cases (OR = 3 . 751, RR = 2 . 323, p \u003C 0. 0001) . rs1403981107 AA was associated with HER2 + BC (OR = 2 . 338, p = 0 . 0177) and metastatic disease (OR = 1 . 680, p = 0 . 0137) . rs1837738907 GA was significantly associated with early-stage BC (OR = 2 . 552, p = 0 . 0002), suggesting its role in early diagnosis.  \nConclusion These results emphasize the functional role of PRKCQ variants in breast cancer and indicate that employing these SNPs as diagnostic, prognostic, and therapeutic biomarkers can be useful for the development of targeted therapeutic strategies. Large sample studies are called for to reinforce these correlations and investigate PKCθ-targeted drugs and their application in breast cancer treatment.  \n*Correspondence:  \nMaria Shabbir [mshabbir@asab.nust.edu.pk](mshabbir@asab.nust.edu.pk)[ ](mshabbir@asab.nust.edu.pk)Suhail Razak[smarazi@ksu.edu.sa](smarazi@ksu.edu.sa)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/l](vecommons.org/l)icenses/by-","cbCaij4DyGHmyOYU","https://ap.wps.com/l/cbCaij4DyGHmyOYU","pdf",1102677,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Background\n## Genetic predisposition and SNP relevance\n## PRKCQ/PKCθ role in signaling and cancer","[{\"question\":\"What does the study investigate about PRKCQ variants?\",\"answer\":\"It examines how five pathogenic missense variants in the PRKCQ gene relate to breast cancer susceptibility, tumor characteristics, and molecular types.\"},{\"question\":\"How were the genetic variants genotyped and analyzed?\",\"answer\":\"Blood samples from patients and controls were processed for DNA extraction via phenol–chloroform, and genotyping was performed using Tetra ARMS PCR. Associations were evaluated using Chi-square and Fisher’s exact tests with GraphPad Prism.\"},{\"question\":\"Which variant-genotype associations were highlighted in the results?\",\"answer\":\"The study reports significant links between specific genotypes and breast cancer risk and phenotype, including rs1248923790 TT with increased risk, and rs1403981107 AA with HER2+ disease and metastatic status.\"}]","Association of PRKCQ variants with breast cancer susceptibility and clinicopathological features | PDF",1790171692,23,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e0ac31c8c59f31a5f598f3a312a287be.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5e6beeb847d9144ae06ca268802091cb.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fa212cd3fb177ded2e98e89176bb5b05.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/10c976d9b2352c9419857f2a0a4929f1.webp",980,1306]